Thyroid-associated ophthalmopathy is a typical autoimmune disease of orbital tissues. Alternative splicing significantly influences many diseases progression, including cancer, age-related macular degeneration, and multiple sclerosis, by modulating the expression of transcripts. However, its role in thyroid-associated ophthalmopathy is still unclear. In this study, differential expression transcripts and differential alternative splicing genes in orbital adipose/connective tissues of thyroid-associated ophthalmopathy patients were detected using RNA sequencing, Cuffdiff, and replicate multivariate analysis of transcript splicing. Three thousand ninety six differential expression transcripts and 2355 differential alternative splicing genes were screened out, while functional enrichment analysis indicated that differential expression transcript and differential alternative splicing genes were associated with immune modulation, extracellular matrix remodeling, and adipogenesis. The expression of the SORBS1, SEPT2, COL12A1, and VCAN gene transcripts was verified by qRT-PCR. In conclusion, prevalent alternative splicing is involved in the disease development in thyroid-associated ophthalmopathy. More attention should be paid to the mechanism of alternative splicing to explore more potential therapeutic targets in thyroid-associated ophthalmopathy.
BahnRS.Graves' ophthalmopathy. N Engl J Med2010;
362:726–38
2.
McGregorAM.Has the target autoantigen for Graves' ophthalmopathy been found?Lancet1998;
352:595–6
3.
WallJRLahootiH.Pathogenesis of thyroid eye disease – does autoimmunity against the TSH receptor explain all cases?Endokrynol Pol2010;
61:222–7
4.
FeldonSEParkDJO'LoughlinCWNguyenVTLandskroner-EigerSChangDThatcherTHPhippsRP.Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy. Invest Ophthalmol Vis Sci2005;
46:3913–21
5.
EcksteinAKJohnsonKTThanosMEsserJLudgateM.Current insights into the pathogenesis of Graves' orbitopathy. Horm Metab Res2009;
41:456–64
6.
ValyaseviRWHarteneckDADuttonCMBahnRS.Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab2002;
87:2352–8
7.
ZhaoPDengYGuPWangYZhouHHuYChenPFanX.Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy. Exp Eye Res2013;
107:65–73
8.
BahnRS.Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy. Thyroid2002;
12:193–5
9.
YangHWWangYXBaoJWangSHLeiPSunZL.Correlation of HLA-DQ and TNF-α gene polymorphisms with ocular myasthenia gravis combined with thyroid-associated ophthalmopathy. Biosci Rep2017;
37:BSR20160440
10.
ZhaoPYinHTaoCChenPSongYYangWLiuL.Latent pathways identification by microarray expression profiles in thyroid-associated ophthalmopathy patients. Endocr Pathol2015;
26:200–10
11.
TongBDXiaoMYZengJXXiongW.MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy. Mol Vis2015;
21:324–34
12.
WuLZhouRDiaoJChenXHuangJXuKLingLXiaWLiangYLiuGSunXQinBZhaoC.Differentially expressed circular RNAs in orbital adipose/connective tissue from patients with thyroid-associated ophthalmopathy. Exp Eye Res2020;
196:108036
13.
WangYLiuJHuangBOXuYMLiJHuangLFLinJZhangJMinQHYangWMWangXZ.Mechanism of alternative splicing and its regulation. Biomed Rep2015;
3:152–8
14.
LinJC.Impacts of alternative splicing events on the differentiation of adipocytes. Int J Mol Sci2015;
16:22169–89
15.
LiuHLorenziniPAZhangFXuSWongMSMZhengJRocaX.Alternative splicing analysis in human monocytes and macrophages reveals MBNL1 as major regulator. Nucleic Acids Res2018;
46:6069–86
16.
Pujol-LereisLMLiebischGSchickTLinYGrassmannFUchidaKZipfelPFFauserSSkerkaCWeberBHF.Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration. PLoS One2018;
13:e0200739
17.
CardamoneGParaboschiEMRimoldiVDugaSSoldàGAsseltaR.The characterization of GSDMB splicing and backsplicing profiles identifies novel isoforms and a circular RNA that are dysregulated in multiple sclerosis. Int J Mol Sci2017;
18:576
18.
FarinaARCappabiancaLSebastianoMZelliVGuadagniSMackayAR.Hypoxia-induced alternative splicing: the 11th hallmark of cancer. J Exp Clin Cancer Res2020;
39:110
19.
BartleyGBGormanCA.Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol1995;
119:792–5
20.
MouritsMPPrummelMFWiersingaWMKoornneefL.Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol1997;
47:9–14
21.
BolgerAMLohseMUsadelB.Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics2014;
30:2114–20
22.
KimDLangmeadBSalzbergSL.HISAT: a fast spliced aligner with low memory requirements. Nat Methods2015;
12:357–60
23.
AndersSPylPTHuberW.HTSeq – a python framework to work with high-throughput sequencing data. Bioinformatics2015;
31:166–9
24.
RobertsAPimentelHTrapnellCPachterL.Identification of novel transcripts in annotated genomes using RNA-Seq. Bioinformatics2011;
27:2325–9
25.
AndersSHuberW.Differential expression analysis for sequence count data. Genome Biol2010;
11:R106
26.
ShenSParkJWLuZXLinLHenryMDWuYNZhouQXingY.rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci U S A2014;
111:E5593–601
27.
WangLCaoCMaQZengQWangHChengZZhuGQiJMaHNianHWangY.RNA-seq analyses of multiple meristems of soybean: novel and alternative transcripts, evolutionary and functional implications. BMC Plant Biol2014;
14:169
28.
GianoukakisAGKhadaviNSmithTJ.Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid2008;
18:953–8
29.
FangSHuangYWangSZhangYLuoXLiuLZhongSLiuXLiDLiangRMirandaPGuPZhouHFanXLiB.IL-17A exacerbates fibrosis by promoting the proinflammatory and profibrotic function of orbital fibroblasts in TAO. J Clin Endocrinol Metab2016;
101:2955–65
30.
LeeGR.The balance of Th17 versus treg cells in autoimmunity. Int J Mol Sci2018;
19:730
31.
BednarczukTStolarskiCPawlikESlonMRowinskiMKubotaSHiromatsuYBartoszewiczZWallJRNaumanJ.Autoantibodies reactive with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy. Thyroid1999;
9:289–95
32.
HeufelderAEScribaPC.Characterization of adhesion receptors on cultured microvascular endothelial cells derived from the retroorbital connective tissue of patients with Grave's ophthalmopathy. Eur J Endocrinol1996;
134:51–60
33.
BednarczukTKiljanskiJMrowiecTSlonMIngEStolarskiCKennerdellJSGorskiANaumanJWallJR.T cell interactions with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy. Autoimmunity1998;
27:221–30
34.
Padilla-BenavidesTVelez-delValleCMarsch-MorenoMCastro-MuñozledoFKuri-HarcuchW.Lipogenic enzymes complexes and cytoplasmic lipid droplet formation during adipogenesis. J Cell Biochem2016;
117:2315–26
35.
CaiHDongLQLiuF.Recent advances in adipose mTOR signaling and function: therapeutic prospects. Trends Pharmacol Sci2016;
37:303–17
36.
GörtzGEMoshkelgoshaSJesenekCEdelmannBHorstmannMBangaJPEcksteinA,
Berchner-Pfannschmidt U. Pathogenic phenotype of adipogenesis and hyaluronan in orbital fibroblasts from female Graves' orbitopathy mouse model. Endocrinology2016;
157:3771–8
37.
Mota de SáPRichardAJHangHStephensJM.Transcriptional regulation of adipogenesis. Compr Physiol2017;
7:635–74
38.
KumarSCoenenMJSchererPEBahnRS.Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy. J Clin Endocrinol Metab2004;
89:930–5
39.
FerrariSMRagusaFPaparoSRNasiniFNardiMFranceschiniSSFallahiPAntonelliA.Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy. Autoimmun Rev2019;
18:673–8
40.
SmithTJJanssenJ.Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy. Endocr Rev2019;
40:236–67
41.
SmithTJKahalyGJEzraDGFlemingJCDaileyRATangRAHarrisGJAntonelliASalviMGoldbergRAGigantelliJWCouchSMShriverEMHayekBRHinkEMWoodwardRMGabrielKMagniGDouglasRS.Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med2017;
376:1748–61
42.
FarinaFGaillardJGuérinCCoutéYSillibourneJBlanchoinLThéryM.The centrosome is an actin-organizing Centre. Nat Cell Biol2016;
18:65–75
43.
Mor-Yossef MoldovanLLustigMNaftalyAMardamshinaMGeigerTGefenABenayahuD.Cell shape alteration during adipogenesis is associated with coordinated matrix cues. J Cell Physiol2019;
234:3850–63
44.
TrivanovićDDrvenicaIKukoljTObradovićHOkić DjordjevićIMojsilovićSKrstićJBugarskiBJaukovićABugarskiD.Adipoinductive effect of extracellular matrix involves cytoskeleton changes and SIRT1 activity in adipose tissue stem/stromal cells. Artif Cells Nanomed Biotechnol2018;
46:S370–82
45.
BarquissauVGhandourRAAilhaudGKlingensporMLanginDAmriEZPisaniDF.Control of adipogenesis by oxylipins, GPCRs and PPARs. Biochimie2017;
136:3–11
46.
ZhangMKimuraASaltielAR.Cloning and characterization of cbl-associated protein splicing isoforms. Mol Med2003;
9:18–25
47.
BaumannCAChokshiNSaltielARRibonV.Cloning and characterization of a functional peroxisome proliferator activator receptor-gamma-responsive element in the promoter of the CAP gene. J Biol Chem2000;
275:9131–5
48.
NeubauerKZiegerB.The mammalian septin interactome. Front Cell Dev Biol2017;
5:3
49.
CaoLQShaoZLLiangHHZhangDWYangXWJiangXFXueP.Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression. Cancer Lett2015;
359:127–35
50.
KochMBohrmannBMatthisonMHagiosCTruebBChiquetM.Large and small splice variants of collagen XII: differential expression and ligand binding. J Cell Biol1995;
130:1005–14
51.
Kloeckener-GruissemBNeidhardtJMagyarIPlauchuHZechJCMorléLPalmer-SmithSMMacdonaldMJNasVFryAEBergerW.Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome. Eur J Hum Genet2013;
21:352–6
52.
FangSHuangYZhongSLiYZhangYLiYSunJLiuXWangYZhangSXuTSunXGuPLiDZhouHLiBFanX.Regulation of orbital fibrosis and adipogenesis by pathogenic Th17cCells in Graves orbitopathy. J Clin Endocrinol Metab2017;
102:4273–83
53.
UenoTFujimoriK.Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB Cascade. FEBS J2011;
278:2901–12
54.
KhongJJWangLYSmythGKMcNabAAHardyTGSelvaDLlamasBJungCHSharmaSBurdonKPEbelingPRCraigJE.Differential gene expression profiling of orbital adipose tissue in thyroid orbitopathy. Invest Ophthalmol Vis Sci2015;
56:6438–47
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
